BOULOGNE-BILLANCOURT, France, June 11, 2025 – Renault Group has made an investment in Wandercraft, a company that designs and manufactures medical self-balancing exoskeletons. Building on its expertise in exoskeleton technology, Wandercraft has developed a versatile platform targeting applications like manufacturing. The investment includes participation from both existing shareholders and new investors alongside Renault Group.
Renault Group and Wandercraft have entered a commercial partnership to develop Calvin, a new line of robots intended for industrial applications. Calvin is designed to reduce workers’ exposure to physically demanding and non-ergonomic tasks while improving production efficiency. The partnership also plans to leverage Renault Group’s expertise in design-to-cost and large-scale manufacturing to industrialize both robots and exoskeletons. This approach aims to lower production costs and support Wandercraft in bringing its new exoskeleton, Eve, to market, expanding opportunities within the robotics sector.
“This partnership with Wandercraft is a forward-looking move. It will allow us to accelerate on automation and to develop robots for our specific auto industrial use, giving us the opportunity to concentrate our people on more value-adding tasks and alleviate operators from painful and non-ergonomics duties. It will drive productivity through the acceleration of production time and costs’ reduction. In the end, it makes a lot of sense to combine Wandercraft’s unique expertise and technology in exoskeletons and robots, with Renault Group’s strong industrial capacity and design-to-cost know-how to bring the production of robots at scale” said Thierry Charvet, chief industry and quality officer of Renault Group.
“Renault Group’s investment marks a defining moment for Wandercraft. This partnership will boost our ability to build and scale high-impact, low-cost robotics that improve the everyday lives of real people – whether it’s helping individuals with disabilities walk or supporting industrial workers through automation – on the factory floor, in clinics and at home. We’re proud to combine our technology with Renault Group’s industrial excellence to deliver the next generation of mobile robotics” said Matthieu Masselin, CEO and co-founder of Wandercraft.
Source: Renault Group
About Renault Group
Renault Group is a French multinational automobile manufacturer founded in 1899 and headquartered in Boulogne-Billancourt, France. The company designs, manufactures, and sells a wide range of vehicles under various brands, including Renault, Dacia, Alpine, and Mobilize. In 2023, Renault Group reported a revenue of €52.4 billion. The group produced approx. 2.5 million vehicles in 2024, with manufacturing operations in France, Spain, and Morocco. It employs more than 98,000 people. Renault Group is also part of the Renault-Nissan-Mitsubishi Alliance, a partnership aimed at enhancing collaboration and innovation in the automotive industry. The company continues to focus on electrification, with plans to launch new EV models in the coming years. The Group’s ambition is to achieve carbon neutrality in Europe by 2040.
About Wandercraft
Wandercraft is a French medical robotics company established in 2012 and headquartered in Paris. It focuses on developing self-balancing robotic exoskeletons to improve mobility for individuals with severe disabilities. Its primary clinical product, Atalante X, is used in rehabilitation centers, while the personal exoskeleton Eve is designed for home and outdoor use. The company has secured substantial funding, including a $75 million Series D round in 2025, to support technology development and commercialization. Wandercraft operates internationally, with a U.S. office in New York City and products deployed in over 100 rehabilitation centers across Europe and North America. The company holds more than 30 patents and maintains over 100 Atalante units in hospitals worldwide. Its exoskeletons generate real-world movement data, which fuels a proprietary neural network driving the next generation of devices, including the recently developed humanoid robot Calvin 40. Wandercraft’s work aims to provide reliable robotic assistance to those with impaired mobility.